SIBN
SI-BONE, Inc.
NasdaqGMUSDEQUITY
Healthcare
DELAYED
Strong buy
+61/100
Last price
19.55
▼ 0.26 (1.31%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
19.60
Prev close
19.81
Day high
20.00
Day low
19.21
Volume
538.73K
Market cap
$876.20M
P/E (TTM)
—
52W range
11.48 – 21.89
Day trading desk
Gap from prior close
-1.06%
Prior close 19.81
VWAP
19.46
+0.45% from price
Relative volume
0.80×
Normal
Session range
4.11%
19.21 – 20.00
Position in range
43%
Mid range
ATR (14D)
0.74
3.77% of price
Prior day high
19.84
PDH
Prior day low
18.26
PDL
Bid / ask spread
—
Quote not published
Session volume
444.90K
Avg 553.00K
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Returnvs SPY
1W
+2.09%
+0.1%
1M
+5.68%
+4.5%
3M
+15.75%
+11.2%
6M
+48.44%
+30.3%
YTD
-0.86%
-15.1%
1Y
+34.83%
+18.4%
3Y
-7.96%
-90.2%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on SIBN open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
-93.84K
Net selling
Buy transactions
11
140.89K shares
Sell transactions
18
234.73K shares
Net transactions
+29
Buys less sells
Sell : buy shares
1.7 : 1
Mixed
Insider-held shares
1.46M
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Oct 1, 26 | DUNN JEFFREY W Director |
SELL | 20.00K | $369.40K | Direct |
| Oct 1, 26 | DUNN JEFFREY W Director |
CONVERSION | 20.00K | $93.60K | Direct |
| Sep 1, 26 | DUNN JEFFREY W Director |
SELL | 20.00K | $378.16K | Direct |
| Sep 1, 26 | DUNN JEFFREY W Director |
CONVERSION | 20.00K | $93.60K | Direct |
| Aug 24, 26 | FRANCIS LAURA A. Chief Executive Officer |
SELL | 25.97K | $522.60K | Indirect |
| Aug 24, 26 | MAHESHWARI ANSHUL Chief Financial Officer |
SELL | 11.64K | $233.97K | Direct |
| Aug 21, 26 | FRANCIS LAURA A. Chief Executive Officer |
SELL | 55.81K | $1.09M | Indirect |
| Aug 21, 26 | MAHESHWARI ANSHUL Chief Financial Officer |
SELL | 16.98K | $337.14K | Direct |
| Aug 17, 26 | FRANCIS LAURA A. Chief Executive Officer |
SELL | 14.96K | $279.06K | Direct |
| Aug 17, 26 | MAHESHWARI ANSHUL Chief Financial Officer |
SELL | 4.67K | $87.02K | Direct |
| Aug 17, 26 | PISETSKY MICHAEL A Officer |
SELL | 3.73K | $69.41K | Direct |
| Aug 3, 26 | DUNN JEFFREY W Director |
SELL | 20.00K | $369.21K | Direct |
| Aug 3, 26 | DUNN JEFFREY W Director |
CONVERSION | 20.00K | $93.60K | Direct |
| Jul 2, 26 | MAHESHWARI ANSHUL Chief Financial Officer |
SELL | 3.32K | $55.63K | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
DAVIS TIMOTHY E JR |
Director | 76.68K | Stock Award(Grant) |
DUNN JEFFREY W |
Director | 97.13K | Sale |
FRANCIS LAURA A. |
Chief Executive Officer | — | Sale |
FREUND JOHN GORDON |
Director | 146.03K | Stock Award(Grant) |
HILLEMAN JERYL L |
Director | 43.77K | Stock Award(Grant) |
HINCKLEY GREGORY K |
Director | 180.74K | Conversion of Exercise of derivative security |
MAHESHWARI ANSHUL |
Chief Financial Officer | 223.28K | Sale |
NISHIMURA MIKA |
Director | 43.67K | Stock Award(Grant) |
PISETSKY MICHAEL A |
Officer | 273.65K | Sale |
RECUPERO ANTHONY JOHN |
Former | 243.42K | Sale |
Fundamentals
Market cap$876.20M
Enterprise value$773.06M
Revenue (TTM)$213.60M
Gross profit$169.87M
EBITDA$-11.32M
Net income$-14.63M
EPS (TTM)$-0.34
Free cash flow$-861.88K
Total cash$145.94M
Total debt$42.80M
Book value / share$4.08
Shares outstanding44.82M
Float39.99M
Short % of float15.38%
Dividend yield0.00%
Beta (5Y)0.66
Valuation & profitability ratios
Trailing P/E—
Forward P/E-59.09
PEG ratio—
Price / sales—
Price / book4.79
EV / revenue3.62
EV / EBITDA-68.26
Gross margin79.53%
Operating margin-8.58%
Profit margin-6.85%
Return on equity-8.30%
Return on assets-4.62%
Debt / equity23.47
Current ratio9.15
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $200.93M | $167.18M | $138.89M | $106.41M | +20.2% |
| Operating revenue | $200.93M | $167.18M | $138.89M | $106.41M | +20.2% |
| Cost of revenue | $41.05M | $35.06M | $29.47M | $15.71M | +17.1% |
| Gross profit | $159.88M | $132.12M | $109.42M | $90.70M | +21.0% |
| Research & development | $17.45M | $16.56M | $15.03M | $13.63M | +5.4% |
| Selling, general & admin | $164.76M | $150.81M | $141.32M | $136.69M | +9.3% |
| Total operating expense | $182.21M | $167.37M | $156.35M | $150.31M | +8.9% |
| Operating income | -$22.33M | -$35.25M | -$46.93M | -$59.61M | +36.6% |
| Net interest income | $3.45M | $4.41M | $3.45M | -$1.51M | -21.8% |
| Pre-tax income | -$18.90M | -$30.91M | -$43.34M | -$61.26M | +38.8% |
| Net income | -$18.90M | -$30.91M | -$43.34M | -$61.26M | +38.8% |
| Net income to common | -$18.90M | -$30.91M | -$43.34M | -$61.26M | +38.8% |
| Basic EPS | -0.44 | -0.75 | -1.13 | -1.79 | +41.3% |
| Diluted EPS | -0.44 | -0.75 | -1.13 | -1.79 | +41.3% |
| EBIT | -$16.28M | -$27.47M | -$39.87M | -$58.44M | +40.8% |
| EBITDA | -$10.51M | -$23.09M | -$34.45M | -$54.98M | +54.5% |
| Basic shares | 42.96M | 41.47M | 38.43M | 34.20M | +3.6% |
| Diluted shares | 42.96M | 41.47M | 38.43M | 34.20M | +3.6% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $42.24M | $34.95M | $33.27M | $20.72M | +20.9% |
| Cash & short-term investments | $147.82M | $150.04M | $166.02M | $97.29M | -1.5% |
| Accounts receivable | $29.91M | $27.46M | $21.95M | $20.67M | +8.9% |
| Inventory | $33.90M | $27.07M | $20.25M | $17.28M | +25.2% |
| Total current assets | $216.12M | $207.78M | $211.39M | $137.61M | +4.0% |
| Property, plant & equipment | $22.39M | $22.36M | $18.71M | $19.57M | +0.1% |
| Total assets | $238.56M | $230.44M | $230.43M | $157.55M | +3.5% |
| Total current liabilities | $25.28M | $27.13M | $23.46M | $21.18M | -6.8% |
| Long-term debt | $35.57M | $35.45M | $36.06M | $35.17M | +0.3% |
| Total debt | $36.69M | $37.48M | $38.99M | $39.43M | -2.1% |
| Total liabilities | $61.02M | $63.47M | $61.05M | $59.25M | -3.9% |
| Retained earnings | -$450.26M | -$431.35M | -$400.44M | -$357.11M | -4.4% |
| Shareholder equity | $177.53M | $166.96M | $169.38M | $98.30M | +6.3% |
| Working capital | $190.84M | $180.65M | $187.94M | $116.43M | +5.6% |
| Net tangible assets | $177.53M | $166.96M | $169.38M | $98.30M | +6.3% |
| Shares issued | 43.65M | 42.09M | 40.69M | 34.73M | +3.7% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | -$18.90M | -$30.91M | -$43.34M | -$61.26M | +38.8% |
| Depreciation & amortisation | $5.77M | $4.38M | $5.43M | $3.45M | +31.8% |
| Stock-based compensation | $25.52M | $25.87M | $24.06M | $23.06M | -1.3% |
| Change in working capital | -$14.32M | -$10.12M | -$4.83M | -$7.96M | -41.6% |
| Operating cash flow | -$675.00K | -$12.43M | -$18.71M | -$41.66M | +94.6% |
| Capital expenditure | -$8.41M | -$10.50M | -$7.80M | -$9.51M | +19.8% |
| Investing cash flow | $4.16M | $12.62M | -$59.80M | -$2.81M | -67.0% |
| Financing cash flow | $3.38M | $1.96M | $90.93M | $2.20M | +72.4% |
| Free cash flow | -$9.09M | -$22.92M | -$26.51M | -$51.16M | +60.3% |
| End cash position | $42.24M | $34.95M | $33.27M | $20.72M | +20.9% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $56.01M | $52.59M | $56.35M | $48.66M | $48.63M | +6.5% |
| Operating revenue | $56.01M | $52.59M | $56.35M | $48.66M | $48.63M | +6.5% |
| Cost of revenue | $11.46M | $10.64M | $11.82M | $9.81M | $9.82M | +7.7% |
| Gross profit | $44.55M | $41.94M | $44.53M | $38.85M | $38.81M | +6.2% |
| Research & development | $5.22M | $4.19M | $4.36M | $4.24M | $4.31M | +24.5% |
| Selling, general & admin | $44.13M | $42.84M | $42.63M | $39.99M | $41.50M | +3.0% |
| Total operating expense | $49.35M | $47.04M | $46.99M | $44.23M | $45.81M | +4.9% |
| Operating income | -$4.81M | -$5.09M | -$2.46M | -$5.38M | -$7.00M | +5.6% |
| Net interest income | $734.00K | $758.00K | $817.00K | $845.00K | $854.00K | -3.2% |
| Pre-tax income | -$4.09M | -$4.33M | -$1.64M | -$4.57M | -$6.15M | +5.7% |
| Net income | -$4.09M | -$4.33M | -$1.64M | -$4.57M | -$6.15M | +5.7% |
| Net income to common | -$4.09M | -$4.33M | -$1.64M | -$4.57M | -$6.15M | +5.7% |
| Basic EPS | -0.09 | -0.10 | -0.04 | -0.11 | -0.14 | +10.0% |
| Diluted EPS | -0.09 | -0.10 | -0.04 | -0.11 | -0.14 | +10.0% |
| EBIT | -$3.49M | -$3.74M | -$1.01M | -$3.90M | -$5.49M | +6.7% |
| EBITDA | -$1.81M | -$2.13M | $624.00K | -$2.41M | -$4.12M | +14.8% |
| Basic shares | 44.48M | 43.96M | 43.51M | 43.19M | 42.79M | +1.2% |
| Diluted shares | 44.48M | 43.96M | 43.51M | 43.19M | 42.79M | +1.2% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $33.13M | $33.53M | $42.24M | $26.49M | $34.15M | -1.2% |
| Cash & short-term investments | $145.94M | $144.68M | $147.82M | $145.74M | $145.54M | +0.9% |
| Accounts receivable | $31.18M | $30.96M | $29.91M | $26.53M | $24.37M | +0.7% |
| Inventory | $38.39M | $35.53M | $33.90M | $35.73M | $34.24M | +8.0% |
| Total current assets | $219.91M | $214.72M | $216.12M | $210.78M | $207.45M | +2.4% |
| Property, plant & equipment | $28.63M | $27.78M | $22.39M | $23.18M | $23.17M | +3.1% |
| Total assets | $248.76M | $242.72M | $238.56M | $234.27M | $230.92M | +2.5% |
| Total current liabilities | $24.04M | $21.49M | $25.28M | $26.44M | $24.75M | +11.9% |
| Long-term debt | $35.63M | $35.60M | $35.57M | $35.54M | $35.51M | +0.1% |
| Total debt | $42.80M | $42.95M | $36.69M | $36.84M | $36.93M | -0.4% |
| Total liabilities | $66.41M | $63.78M | $61.02M | $62.15M | $60.58M | +4.1% |
| Retained earnings | -$458.68M | -$454.59M | -$450.26M | -$448.61M | -$444.05M | -0.9% |
| Shareholder equity | $182.35M | $178.94M | $177.53M | $172.13M | $170.34M | +1.9% |
| Working capital | $195.87M | $193.23M | $190.84M | $184.34M | $182.70M | +1.4% |
| Net tangible assets | $182.35M | $178.94M | $177.53M | $172.13M | $170.34M | +1.9% |
| Shares issued | 44.70M | 44.20M | 43.65M | 43.27M | 43.01M | +1.1% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Net income | -$4.09M | -$4.33M | -$1.64M | -$4.57M | -$6.15M | +5.7% |
| Depreciation & amortisation | $1.68M | $1.62M | $1.64M | $1.49M | $1.37M | +3.8% |
| Stock-based compensation | $5.98M | $6.03M | $5.98M | $6.23M | $6.66M | -0.8% |
| Change in working capital | -$2.60M | -$5.95M | -$4.09M | -$1.56M | -$2.47M | +56.3% |
| Operating cash flow | $777.00K | -$2.36M | $1.73M | $2.33M | $173.00K | +132.9% |
| Capital expenditure | -$1.54M | -$1.08M | -$1.29M | -$2.96M | -$2.10M | -43.5% |
| Investing cash flow | -$2.74M | -$6.23M | $13.03M | -$10.03M | -$9.47M | +56.1% |
| Financing cash flow | $1.63M | $34.00K | $1.03M | $11.00K | $2.23M | +4,688.2% |
| Free cash flow | -$768.00K | -$3.44M | $440.00K | -$620.00K | -$1.93M | +77.7% |
| End cash position | $33.13M | $33.53M | $42.24M | $26.49M | $34.15M | -1.2% |
Options analytics
Put / call volume
79.63
Put-heavy session
Put / call open interest
1.57
Positioning, not flow
Max pain
10.00
-48.8% from spot
ATM implied vol
3.1%
Nearest strike to spot
Skew (10% OTM)
0.0%
Calls bid over puts
Call volume
24
Contracts, this expiry
Put volume
1.91K
Contracts, this expiry
Heaviest call OI
2.50
6 contracts
Heaviest put OI
10.00
7 contracts
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jun 2026 | -0.15 | -0.09 | +39.9% |
| Mar 2026 | -0.19 | -0.10 | +47.8% |
| Dec 2025 | -0.13 | -0.04 | +68.1% |
| Sep 2025 | -0.17 | -0.11 | +33.3% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | -0.13 | 8 | $55.32M | +13.7% |
| Next quarter | -0.07 | 8 | $68.23M | +21.1% |
| Current year | -0.40 | 8 | $232.13M | +15.5% |
| Next year | -0.33 | 8 | $268.44M | +15.6% |
Analyst targets & ownership
Mean target$25.22
High target$32.00
Low target$20.00
Implied upside29.01%
Analyst count9
ConsensusSTRONG BUY
Strong buy / Buy3 / 6
Hold0
Sell / Strong sell0 / 0
Held by insiders3.27%
Held by institutions109.60%
Institutions holding240
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
18.83
+3.84% from price
SMA 20
18.63
+4.96% from price
SMA 50
18.76
+4.24% from price
SMA 100
17.32
+12.87% from price
SMA 200
16.35
+19.60% from price
EMA 12
18.87
+3.58% from price
EMA 26
18.74
+4.32% from price
EMA 50
18.41
+6.20% from price
RSI (14)
58.9
Neutral
MACD (12,26,9)
0.13
Hist 0.09
ATR (14)
0.74
3.77% of price
Realised vol 30D
33.9%
Annualised
Bollinger upper
19.51
20, 2σ
Bollinger lower
17.75
20, 2σ
50 / 200 cross
Golden
18.76 vs 16.35
Trend bias
Above 200
+19.60%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
0.61
Less volatile than market
Correlation to SPY
0.16
Largely independent
Realised vol 30D
33.9%
Annualised
Market vol 1Y
13.0%
SPY, annualised
Max drawdown 1Y
-45.7%
Peak to trough
Max drawdown 5Y
-59.8%
Peak to trough
ATR 14
0.74
3.77% of price
Beta (reported)
0.66
5Y monthly, from filing
Short interest
Shares short
5.91M
Prior 5.34M
Change vs prior
+10.8%
Shorts adding
% of float
15.38%
Elevated
% of shares out
13.20%
Against total outstanding
Days to cover
10.4
Crowded exit
Float
39.99M
Freely tradeable shares
Exchanges publish short interest twice a month with a settlement lag, so this is roughly two weeks behind. Days to cover divides shares short by average daily volume — it estimates how long covering would take, not whether it will happen.
Rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Aug 4, 26 | UBS | MAINTAINED | Buy | Buy |
| Aug 4, 26 | Truist Securities | MAINTAINED | Buy | Buy |
| Aug 4, 26 | TD Cowen | MAINTAINED | Buy | Buy |
| Jul 28, 26 | UBS | INITIATED | — | Buy |
| Jul 16, 26 | Truist Securities | MAINTAINED | Buy | Buy |
| May 12, 26 | TD Cowen | MAINTAINED | Buy | Buy |
| May 12, 26 | Truist Securities | MAINTAINED | Buy | Buy |
| Apr 15, 26 | Truist Securities | MAINTAINED | Buy | Buy |
| Feb 24, 26 | TD Cowen | MAINTAINED | Buy | Buy |
| Feb 24, 26 | Truist Securities | MAINTAINED | Buy | Buy |
| Jan 27, 26 | TD Cowen | INITIATED | — | Buy |
| Dec 18, 25 | Truist Securities | MAINTAINED | Buy | Buy |
Dividends & splits
Forward rate—
Forward yield0.00%
5-year avg yield—
Payout ratio—
Ex-dividend date—
Next pay date—
Last split—
Split date—
SEC filings
Corporate Changes & Voting Matters
8-K · 2026-09-11
Periodic Financial Reports
10-Q · 2026-08-04
Corporate Changes & Voting Matters
8-K · 2026-08-03
Corporate Changes & Voting Matters
8-K · 2026-06-08
Corporate Changes & Voting Matters
8-K · 2026-05-11
Annual Report to Shareholders
ARS · 2026-04-21
Offering Registrations
S-8 · 2026-02-24
Corporate Changes & Voting Matters
8-K · 2026-02-23
Headlines
SI-BONE Receives FDA 510(k) Clearance for iFuse Granite Onyx™, Extending Its Compromised Bone Franchise Beyond the Pelvis
GlobeNewswire · 8d ago
SI-BONE To Present at Morgan Stanley 24th Global Healthcare Conference on September 14, 2026
GlobeNewswire · 36d ago
Si-Bone (SIBN) is a Great Momentum Stock: Should You Buy?
Zacks · 43d ago
Wall Street Analysts Believe Si-Bone (SIBN) Could Rally 25.25%: Here's is How to Trade
Zacks · 44d ago
Si-Bone Insider Sold Shares Worth $337,138, According to a Recent SEC Filing
MT Newswires · 46d ago
Si-Bone Insider Sold Shares Worth $1,088,201, According to a Recent SEC Filing
MT Newswires · 46d ago
SI-BONE (SIBN) Q2 2026 Earnings Call Transcript
Motley Fool · 57d ago
Does Si-Bone (SIBN) Have the Potential to Rally 38.58% as Wall Street Analysts Expect?
Zacks · 62d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.